Top compounds associated with response to CLDN11


Feature Type Standardized
Nominal ANOVA
mRNA Crizotinib GDSC1000 pan-cancer AAC -0.0018 1
mRNA BRD8899 CTRPv2 pan-cancer AAC 0.0012 1
mRNA ML203 CTRPv2 pan-cancer AAC -0.001 1
mRNA Bexarotene CTRPv2 pan-cancer AAC -0.00099 1
mRNA NSC23766 CTRPv2 pan-cancer AAC -0.00091 1
mRNA Pazopanib FIMM pan-cancer AAC 0.0049 1
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.0008 1
mRNA Mitomycin-C CTRPv2 pan-cancer AAC -0.00071 1
mRNA JQ-1 CTRPv2 pan-cancer AAC -0.00066 1
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.00066 1
Download CSV